ZEMA Pharma Consulting ApS

CVR 42680427 · Private limited company (ApS) · Active · Low risk

ZEMA Pharma Consulting ApS is a Private limited company (ApS), founded on , based in Dyssegård. The company is registered in the industry virksomhedsrådgivning og anden ledelsesrådgivning. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 4 annual reports have been published. The latest annual report (30 Sep 2025) shows equity of DKK 355k and a net result of DKK -217k. CEO: Mads Torkild Hansen.

Bankruptcy risk for ZEMA Pharma Consulting ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Equity ratio40%–60% · bankruptcy rate 4.6%0.52×
Negative equityNo · bankruptcy rate 5.1%0.58×
Share of late annual reports< 0.01% · bankruptcy rate 5.2%0.59×
Current ratio150%–200% · bankruptcy rate 5.4%0.61×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
42680427
Status
Active
Company type
Private limited company (ApS)
Founded
(5 years)
Address
Hjemmevej 42
2870 Dyssegård
Municipality
Gentofte
Industry
Virksomhedsrådgivning og anden ledelsesrådgivning (702000)
Bankruptcies in the industry: Virksomhedsrådgivning og anden rådgivning om driftsledelse
Share capital
DKK 40k
Auditor
Beierholm
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 4
Missing annual reportNo
Negative equityNo
Equity ratio44.9%
Current ratio182%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 102kDKK 131k
Net profitDKK -217kDKK -282k
EquityDKK 355kDKK 571k
Total assetsDKK 789kDKK 630k
CashDKK 25k–
Short-term debtDKK 434k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 30 Sep 202535
1 Oct 2023 – 30 Sep 202423
1 Oct 2022 – 30 Sep 202340
15 Sep 2021 – 30 Sep 202217

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOMads Torkild HansenCurrent
Owner (100%)Mads Torkild HansenCurrent
FounderMads Torkild HansenCurrent

The CEOs' other companies

Mads Torkild Hansen – 1 other companies

Address history (1 moves)

Hjemmevej 42, 2870 Dyssegård
Hjemmevej 42, 2870 Dyssegård

Similar companies in Gentofte

Questions and answers about ZEMA Pharma Consulting ApS

Has ZEMA Pharma Consulting ApS gone bankrupt?

No, ZEMA Pharma Consulting ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of ZEMA Pharma Consulting ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of ZEMA Pharma Consulting ApS?

Mads Torkild Hansen is the CEO of ZEMA Pharma Consulting ApS.

Who is the auditor of ZEMA Pharma Consulting ApS?

ZEMA Pharma Consulting ApS most recently used Beierholm.

When was ZEMA Pharma Consulting ApS founded?

ZEMA Pharma Consulting ApS was founded on 15 September 2021.

What is the equity of ZEMA Pharma Consulting ApS?

Equity was DKK 355k according to the annual report for the period ending 30 September 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.